Navigation Links
Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
Date:11/1/2007

combination with ribavirin. ACHIEVE 2/3 enrolled 933 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C. ACHIEVE 1, the first of the two global Phase 3 trials, completed enrollment of 1331 treatment-naive patients with genotype 1 chronic hepatitis C in August 2007. The Company originally projected completing enrollment of the Phase 3 trials by the end of 2007. HGS expects to have all Phase 3 data available by spring 2009 to support the filing of global marketing authorization applications by fall 2009. Albuferon is being developed by HGS and Novartis under an exclusive worldwide co- development and commercialization agreement entered into in June 2006. HGS received a $40 million milestone payment from Novartis in the third quarter of 2007 for the successful completion of a Phase 2b trial of Albuferon in treatment-naive patients with chronic hepatitis C.

Albuferon requires half as many injections as Pegasys (peginterferon alfa- 2a), the current market leader, and Phase 2 clinical results suggest that Albuferon may offer efficacy at least comparable to Pegasys, with comparable safety and the potential for less impairment of quality of life and daily activity during treatment. HGS believes that Albuferon could become the interferon of choice for the treatment of hepatitis C.

The final results of Phase 2 trials of Albuferon will be presented at the annual meeting of the American Association for the Study of Liver Disease in Boston, November 2-6, 2007.

LymphoStat-B: Enrollment of Phase 3 Trials Progressing

Enrollment of both pivotal Phase 3 trials of LymphoStat-B (belimumab) in patients with active systemic lupus erythematosus (SLE) is progressing. HGS expects to complete enrollment as previously indicated in 2008. LymphoStat-B is being developed by HGS and GSK under a definitive co-development and commercialization agreement entered into in August 2006.

Based on Phase 2 clinical results, HGS believes that LymphoStat-B could
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... , March 31, 2015   Mapi ... Mapi,s Medical Affairs and global Risk Management strength ... previously announced acquisition . ... conducted by a global team that includes physicians, ... decades of experience in navigating complex safety requirements ...
(Date:3/31/2015)... SALT LAKE CITY , March 31, 2015 /PRNewswire-USNewswire/ ... second milestone with the selection of ten proposals ... The MCRI is the first patient-led, scientifically validated ... patients. Stage 2 of the MCRI ... "After careful review of a large number of ...
(Date:3/31/2015)... YORK , March 31, 2015  PlasmaTech ... company advancing protein biologic therapies and oncology supportive ... partner, Hanmi Pharmaceutical Co., Ltd ("Hanmi") (KSE: 128940) ... country,s Ministry of Food and Drug Safety ("MFDS") ... for MuGard, its oncology supportive-care treatment for the ...
(Date:3/31/2015)... March 31, 2015  University of Illinois, ... will deliver the plenary session address on Monday, May ... Symposium (IMS) , kicking off a week of more ... the intersection of RF and microwave technologies with health. ... Radios, Sensors and Circuits for the Skin," will focus ...
Breaking Biology Technology:Mapi expands Pharmacovigilance and Risk Management capabilities 2Mapi expands Pharmacovigilance and Risk Management capabilities 3Myeloma Crowd Research Initiative Selects 10 High-Risk Multiple Myeloma Proposals For Further Review 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 2PlasmaTech Biopharmaceuticals' Partner Hanmi Pharmaceuticals Receives Marketing Approval For MuGard In Korea 3Health and Engineering Converge at the 2015 International Microwave Symposium 2Health and Engineering Converge at the 2015 International Microwave Symposium 3
... Capital Growth and Research held their conference at Grainger Hall. ... way to attract venture capital to Wisconsin, according to the ... conference on Friday at UW-Madisons Grainger Hall. , ,We believe ... John Neis , a senior partner at Venture ...
... are entering into a major war. We must take ... we have already entered a new front line where ... this brand-new mega-search-engine-driven e-commerce marketplace. , ,E-commerce is causing ... the front lines know exactly who is winning and ...
... Communications , a Minnesota firm that makes networking products ... InfiniBand market. InfiniBand, a type of low-latency network, is ... it an edge over Ethernet. , ,For Small Tree, ... Apple market, the product represents a new direction. , ...
Cached Biology Technology:Wisconsin investors seek regional partners and informed legislature 2Wisconsin investors seek regional partners and informed legislature 3Global branding is now a war 2Global branding is now a war 3Global branding is now a war 4Small Tree brings InfiniBand to Apple Xserve G5 clusters 2Small Tree brings InfiniBand to Apple Xserve G5 clusters 3
(Date:3/31/2015)... , March 31, 2015   Guidepoint , ... launch of the Post-Surgical Pain Management TRACKER, part of ... tracking usage trends in the medical device and therapeutics ... to data including treatment volumes, market share, and adoption ... pain associated with joint surgery. The Post-Surgical ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
(Date:3/26/2015)... -- The Granite Club, Canada,s ... today announced it has implemented a state-of-the-art access and ... members and staff, while restricting access to authorized users ... FST,s IMID Access system because it has the perfect ... staff, in addition to unparalleled security," said James ...
Breaking Biology News(10 mins):Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2
... you a healthy tan. The study, led by Dr Ian Stephen ... rich in fruit and vegetables gives you a more healthy golden ... of heading for the sun the best way to look good ... the journal Evolution and Human Behaviour . Dr Ian ...
... Nine researchers from Iowa State University two of them ... Laboratory have been named fellows of the American Association ... AAAS fellows and their award citations are: ... Munas Mehl Professor of Computer Engineering, "For distinguished contributions to ...
... "Substances that appear at first glance to be harmless ... form new, allergenic substances from them, giving rise to ... isothiocyanates, which are formed on the skin following repeated,contact ... Chemistry at the University of,Gothenburg. Around one in ...
Cached Biology News:Looking good on greens 2AAAS honors Iowa State, Ames Lab researchers for distinguished science 2Knee protectors can form allergenic substances on the skin 2